论文部分内容阅读
多年来用吸附流脑菌苗预防流脑,发病率虽有下降,但效果仍不理想。1983年起我们改用“冻干A 群流脑多糖菌苗”,为考核其效果选择了491例13岁以下儿童进行接种反应观察,其中386例还做了血清抗体调查。流脑多糖菌苗系兰州生物制品所供给,每人一次皮下注射0.2毫升于接种后6、24、48、72小时观察体温和局部红晕,免疫前免疫后一个月各耳垂采血一次,用微量间接血凝法测定抗体滴度。491例观察对象中,70.88%出现全身反应,
Over the years with the adsorption of meningitis vaccine to prevent meningitis, although the incidence decreased, but the effect is still not satisfactory. Since 1983, we have switched from “Lyophilized A-cerebrospinal-cerebrospinal fluid vaccine” to selecting 491 children under 13 years of age for vaccination response. 386 of them also did a serum antibody test. Department of meningitis polysaccharides Lanzhou biological products supply, once per subcutaneous injection of 0.2 ml at 6,24,48,72 hours after inoculation observed body temperature and local flush, immunization before the month after the earlobe blood leaching once, with a small amount of indirect Hemagglutination assay for antibody titers. Of the 491 observed subjects, 70.88% had systemic reactions,